Characterization of acute lymphoblastic leukemia progenitor cells.

Blood
Charlotte V CoxAllison Blair

Abstract

Only some acute lymphoblastic leukemia (ALL) cells are thought to be capable of proliferating to maintain the leukemic clone, and these cells may be the most relevant to target with treatment regimens. We have developed a serum-free suspension culture (SC) system that supported growth of B-ALL cells from 33 patients for up to 6 weeks. ALL cells from 28 cases (85%) were expanded in this system, and growth was superior in SC than in long-term bone marrow culture. To characterize ALL progenitors, cells were sorted for expression of CD34 and CD10 or CD19 and the subfractions assayed in SC and in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. Cells capable of long-term proliferation in vitro and NOD/SCID repopulation were derived only from the CD34(+)/CD10(-) and CD34(+)/CD19(-) subfractions, and these cells could engraft secondary recipients. The engrafted cells had the same immunophenotype and karyotype as was seen at diagnosis, suggesting they had differentiated in vivo. These results demonstrate that ALL cells capable of long-term proliferation in vitro and in vivo are CD34(+)/CD10(-)/CD19(-). This suggests that cells with a more immature phenotype, rather than committed B-lymphoid cells, may be the targets f...Continue Reading

References

Nov 1, 1990·Journal of Clinical Pathology·S A Dilly, C J Jagger
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·F M Uckun, J A Ledbetter
Mar 1, 1993·British Journal of Cancer·M F Greaves
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Greaves

❮ Previous
Next ❯

Citations

Sep 18, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Sarah K Brennan, William Matsui
Oct 5, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Boyan K Garvalov, Till Acker
Nov 26, 2010·Annals of Hematology·Ugo Testa
Sep 5, 2009·Breast Cancer Research and Treatment·Jessica C LawsonAdrienne L Edkins
Aug 14, 2012·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Di WangLiang Huang
Sep 29, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·José A Martínez-ClimentFelipe Prosper
Feb 24, 2009·Bone Marrow Transplantation·T LinW Matsui
Dec 11, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher Y ParkIrving L Weissman
Dec 5, 2008·Nature·Elsa QuintanaSean J Morrison
Jul 17, 2008·Nature Clinical Practice. Neurology·Sunit DasJohn A Kessler
Apr 24, 2008·Nature Clinical Practice. Oncology·Andreas Trumpp, Otmar D Wiestler
May 24, 2005·Nature Medicine·Anders CastorSten Eirik W Jacobsen
Apr 2, 2005·Nature Reviews. Cancer·Brian J P Huntly, D Gary Gilliland
Sep 23, 2006·The New England Journal of Medicine·Craig T JordanMark Noble
Feb 13, 2013·The Journal of Experimental Medicine·Christian SchürchAdrian F Ochsenbein
Feb 10, 2012·Antioxidants & Redox Signaling·Xiaoke ShiJingxuan Pan
Jan 7, 2010·The Journal of Clinical Investigation·Natasha Y FrankMarkus H Frank
Nov 6, 2008·Blood·Florence ArmstrongFrançoise Pflumio
Jan 17, 2009·Blood·Charlotte V CoxAllison Blair
Nov 23, 2012·Pharmacogenomics·Soizic GuihardMeyling H Cheok
Mar 20, 2014·Veterinary Immunology and Immunopathology·Daisuke ItoJaime F Modiano
May 14, 2014·Advances in Biological Regulation·Alberto M MartelliFrancesca Chiarini
Jul 30, 2008·Stem Cell Reviews·Stephanie MaXin-Yuan Guan
May 2, 2009·Blood·Olaf Heidenreich, Josef Vormoor
Apr 1, 2013·Drug Delivery and Translational Research·Timothy E AndrewsDaniel A Harki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.